Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6651
|
pubmed:dateCreated |
1997-11-3
|
pubmed:abstractText |
Deposition of amyoid-beta peptide in the central nervous system is a hallmark of Alzheimer's disease and a possible cause of neurodegeneration. The factors that initiate or promote deposition of amyloid-beta peptide are not known. The transforming growth factor TGF-beta1 plays a central role in the response of the brain to injury, and increased TGF-beta1 has been found in the central nervous system of patients with Alzheimer's disease. Here we report that TGF-beta1 induces amyloid-beta deposition in cerebral blood vessels and meninges of aged transgenic mice overexpressing this cytokine from astrocytes. Co-expression of TGF-beta1 in transgenic mice overexpressing amyloid-precursor protein, which develop Alzheimer's like pathology, accelerated the deposition of amyloid-beta peptide. More TGF-beta1 messenger RNA was present in post-mortem brain tissue of Alzheimer's patients than in controls, the levels correlating strongly with amyloid-beta deposition in the damaged cerebral blood vessels of patients with cerebral amyloid angiopathy. These results indicate that overexpression of TGF-beta1 may initiate or promote amyloidogenesis in Alzheimer's disease and in experimental models and so may be a risk factor for developing Alzheimer's disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0028-0836
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
9
|
pubmed:volume |
389
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
603-6
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:9335500-Aged,
pubmed-meshheading:9335500-Aging,
pubmed-meshheading:9335500-Alzheimer Disease,
pubmed-meshheading:9335500-Amyloid beta-Peptides,
pubmed-meshheading:9335500-Amyloidosis,
pubmed-meshheading:9335500-Animals,
pubmed-meshheading:9335500-Astrocytes,
pubmed-meshheading:9335500-Brain,
pubmed-meshheading:9335500-Cerebral Amyloid Angiopathy,
pubmed-meshheading:9335500-Humans,
pubmed-meshheading:9335500-Mice,
pubmed-meshheading:9335500-Mice, Inbred BALB C,
pubmed-meshheading:9335500-Mice, Transgenic,
pubmed-meshheading:9335500-Thiazoles,
pubmed-meshheading:9335500-Transforming Growth Factor beta
|
pubmed:year |
1997
|
pubmed:articleTitle |
Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.
|
pubmed:affiliation |
Gladstone Molecular Neurobiology Program and Department of Neurology, University of California, San Francisco 94141-9100, USA. Tony_Wyss@quickmail.ucsf.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|